Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 408492 27 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107987097B reveals a cost-effective synthesis for 2,6-dichloropyridine-4-boronic ester, eliminating expensive iridium catalysts for scalable pharmaceutical manufacturing.